<DOC>
	<DOCNO>NCT00368966</DOCNO>
	<brief_summary>The purpose study assess safety , tolerability immunogenicity 13-valent pneumococcal conjugate ( 13vPnC ) vaccine compare Prevenar ( 7vPnC ) , give concomitantly routine pediatric vaccination Spain .</brief_summary>
	<brief_title>Study Evaluate 13-valent Pneumococcal Conjugate Vaccine Infants .</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Healthy 2monthold infant Available entire study period Exclusion criterion : Previous vaccination vaccine start study Known contraindication vaccination</criteria>
	<gender>All</gender>
	<minimum_age>42 Days</minimum_age>
	<maximum_age>98 Days</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Pneumococcal</keyword>
	<keyword>Pediatric</keyword>
	<keyword>Vaccine</keyword>
</DOC>